Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed May 10, 2022 · 10-Q · 40 days after period end · 0000950170-22-008741
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$40.67M | -$34.84M | -$20.14M | -$1.25M |
| EPS Diluted | -$1.07 | -$0.96 | -$0.62 | -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 10, 2022 · 40 d after period end
